AlphaFold: Momentary or Revolutionary?

<!doctype html><html lang="en"><head> <meta charset="utf-8"> <title>AlphaFold: Momentary or Revolutionary?</title> <link rel="shortcut icon" href="https://oxfordglobal.com/hubfs/OXFORD_GLOBAL-LOGO_SYMBOL.jpg"> <meta name="description" content="AlphaFold, using AI/ML to predict the structures of proteins, has jumped off the pages of sci-fi and landed into the labs of researchers… but is it any good?"> <meta name="viewport" content="width=device-width, initial-scale=1"> <meta property="og:description" content="AlphaFold, using AI/ML to predict the structures of proteins, has jumped off the pages of sci-fi and landed into the labs of researchers… but is it any good?"> <meta property="og:title" content="AlphaFold: Momentary or Revolutionary?"> <meta name="twitter:description" content="AlphaFold, using AI/ML to predict the structures of proteins, has jumped off the pages of sci-fi and landed into the labs of researchers… but is it any good?"> <meta name="twitter:title" content="AlphaFold: Momentary or Revolutionary?"> <style> a.cta_button{-moz-box-sizing:content-box !important;-webkit-box-sizing:content-box !important;box-sizing:content-box !important;vertical-align:middle}.hs-breadcrumb-menu{list-style-type:none;margin:0px 0px 0px 0px;padding:0px 0px 0px 0px}.hs-breadcrumb-menu-item{float:left;padding:10px 0px 10px 10px}.hs-breadcrumb-menu-divider:before{content:'›';padding-left:10px}.hs-featured-image-link{border:0}.hs-featured-image{float:right;margin:0 0 20px 20px;max-width:50%}@media (max-width: 568px){.hs-featured-image{float:none;margin:0;width:100%;max-width:100%}}.hs-screen-reader-text{clip:rect(1px, 1px, 1px, 1px);height:1px;overflow:hidden;position:absolute !important;width:1px} </style> <link rel="stylesheet" href="https://oxfordglobal.com/hs-fs/hub/8696823/hub_generated/template_assets/135726131582/1732113079147/git/og-stage/css/main.min.css"> <link rel="stylesheet" href="https://cdn.oxfordglobal.com/fontawesome/6.5.1/css/fontawesome.min.css"> <link rel="stylesheet" href="https://cdn.oxfordglobal.com/fontawesome/6.5.1/css/brands.min.css"> <link rel="stylesheet" href="https://cdn.oxfordglobal.com/fontawesome/6.5.1/css/solid.min.css">  <style id="hs_editor_style" type="text/css"> #hs_cos_wrapper_module_17019620504109 { display: block !important; margin-bottom: 0px !important } </style>  <script> var _hsp = window._hsp = window._hsp || []; window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} var useGoogleConsentModeV2 = true; var waitForUpdateMillis = 1000; if (!window._hsGoogleConsentRunOnce) { window._hsGoogleConsentRunOnce = true; gtag('consent', 'default', { 'ad_storage': 'denied', 'analytics_storage': 'denied', 'ad_user_data': 'denied', 'ad_personalization': 'denied', 'wait_for_update': waitForUpdateMillis }); if (useGoogleConsentModeV2) { _hsp.push(['useGoogleConsentModeV2']) } else { _hsp.push(['addPrivacyConsentListener', function(consent){ var hasAnalyticsConsent = consent && (consent.allowed || (consent.categories && consent.categories.analytics)); var hasAdsConsent = consent && (consent.allowed || (consent.categories && consent.categories.advertisement)); gtag('consent', 'update', { 'ad_storage': hasAdsConsent ? 'granted' : 'denied', 'analytics_storage': hasAnalyticsConsent ? 'granted' : 'denied', 'ad_user_data': hasAdsConsent ? 'granted' : 'denied', 'ad_personalization': hasAdsConsent ? 'granted' : 'denied' }); }]); } } gtag('js', new Date()); gtag('set', 'developer_id.dZTQ1Zm', true); gtag('config', 'G-43QK8SYTST'); </script> <script async src="https://www.googletagmanager.com/gtag/js?id=G-43QK8SYTST"></script>  <link rel="canonical" href="https://oxfordglobal.com/discovery-development/resources/alphafold-momentary-or-revolutionary"> <meta property="og:image" content="https://oxfordglobal.com/hubfs/Website/Images/Resources/Discovery/AdobeStock_32008243-scaled.jpg"> <meta name="twitter:image" content="https://oxfordglobal.com/hubfs/Website/Images/Resources/Discovery/AdobeStock_32008243-scaled.jpg"> <meta property="og:url" content="https://oxfordglobal.com/discovery-development/resources/alphafold-momentary-or-revolutionary"> <meta name="twitter:card" content="summary"> <meta http-equiv="content-language" content="en"> <meta name="generator" content="HubSpot"></head> <body class="discovery-development"> <div class="body-wrapper hs-content-id-177028096592 hs-site-page page "> <div data-global-resource-path="git/og-stage/templates/partials/header.html"> <header class="website-header "> <div class="navbar"> <div class="navbar-brands"> <a href="/discovery-development" class="logo-link current-brand"> <img src="https://oxfordglobal.com/hubfs/Website/Logos/Brand%20Logos/Discovery%20%26%20Development.svg" class="logo-image"> <i class="dropdown fa-solid fa-chevron-down"></i> </a> <div class="brands"> <div class="intro"> <h2> Explore our brands </h2> <div class="desc"> Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges. </div> </div> <div class="items"> <div class="item primary-brand"> <a href="/" class="logo-link"><img src="https://oxfordglobal.com/hubfs/logo.jpg" class="logo-image"></a> </div> <div class="item"> <a href="/precision-medicine" class="logo-link"><img src="https://oxfordglobal.com/hubfs/Website/Logos/Brand%20Logos/Precision%20Medicine.svg" class="logo-image"></a> </div> <div class="item active-item"> <a href="/discovery-development" class="logo-link"><img src="https://oxfordglobal.com/hubfs/Website/Logos/Brand%20Logos/Discovery%20%26%20Development.svg" class="logo-image"></a> </div> <div class="item"> <a href="/nextgen-biomed" class="logo-link"><img src="https://oxfordglobal.com/hubfs/Website/Logos/Brand%20Logos/NextGen%20Biomed.svg" class="logo-image"></a> </div> </div> </div> </div> <div class="flex flex-align-center navbar-nav"> <a href="#" class="navbar-nav-toggle"> <div class="toggle-icons"> <i class="fa-solid fa-bars toggle-open"></i> <i class="fa-solid fa-xmark toggle-close"></i> </div> </a> <ul class="navbar-nav-items"> <li class="navbar-nav-item"> <a href="#" class="navbar-nav-item-link">Events <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-graphics"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Header%20Events.jpg" class="subnav-image"> </div> <div class="subnav-items"> <div class="subnav-item flex-3 divider g-20"> <div class="subnav-item-content bottom-mp-fix"> <h3> In-Person & Online Events </h3> <p>Pivotal moments where high-level industry experts and thought leaders come together for focused knowledge sharing and unparalleled networking opportunities.</p> </div> <div class="subnav-item"> <div class="event-pills"> <a href="/discovery-development/events/discovery-development-europe-2025" class="pill center"> <div class="b">Discovery & Development Europe 2025</div> <div class="heading-smallcaps"> 01 - 02 Jul 2025 | Basel, Switzerland </div> </a> <a href="/discovery-development/events/discovery-development-us-2025" class="pill center"> <div class="b">Discovery & Development US 2025</div> <div class="heading-smallcaps"> 02 - 03 Oct 2025 | San Diego, CA </div> </a> </div> </div> </div> <div class="subnav-item flex-2"> <div class="subnav-item-content bottom-mp-fix"> <h3> Online Activities </h3> <p>Our Monthly Science Exchanges and Webinars keep you connected to the conversation.</p> </div> <div class="online-activities-list flex flex-column g-10">  <div class="online-activity"> <a href="/discovery-development/online#Controlled%20Release%20Formulations" class="cta" target="_blank"> <h3 class="other-resources">26/06/24 - Controlled Release Formulations</h3> </a> </div> </div> <div class="subnav-item-content-more"> <a href="/discovery-development/online" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> All Online Activities</a> </div> </div> </div> </div> </li> <li class="navbar-nav-item"> <a href="#" class="navbar-nav-item-link">Community <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-graphics"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Header%20Community.jpg" class="subnav-image"> </div> <div class="subnav-items"> <div class="subnav-item flex flex-1 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> About </h3> <p>We empower scientific decision-makers from the world’s most innovative biopharma organisations to make informed pipeline decisions in early R&D, accelerating their route from target ID to novel clinical candidate.</p> </div> <div class="subnav-item-content-more"> <a href="/discovery-development/about" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> <div class="subnav-item flex flex-1 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> Community </h3> <p>Our community extends across the entire early R&D ecosystem, including biopharma, solution providers, start-ups, academics, and investors.</p> </div> <div class="subnav-item-content-more"> <a href="/discovery-development/community" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> <div class="subnav-item flex flex-1 "> <div class="subnav-item-content bottom-mp-fix"> <h3> Media Partners </h3> <p>We work with leading journal publications on reciprocal marketing arrangements.</p> </div> <div class="subnav-item-content-more"> <a href="/discovery-development/media-partners" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> </div> </div> </li> <li class="navbar-nav-item"> <a href="#" class="navbar-nav-item-link">Services <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-graphics"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Header%20Services.jpg" class="subnav-image"> </div> <div class="subnav-items"> <div class="subnav-item flex flex-1 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> In-Person Services </h3> <p>At Oxford Global, our events are designed to connect key life science figures and innovative solution providers, accelerating scientific advancement. Our goal is to create valuable connections and an impactful experience through innovative and collaborative formats.</p> </div> <div class="subnav-item-content-more"> <a href="/discovery-development/in-person-services" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> <div class="subnav-item flex flex-1"> <div class="subnav-item-content bottom-mp-fix"> <h3> Digital Marketing Services </h3> <p>Oxford Global’s products offer a powerful channel to associate your brand with the latest advancements within the industry whilst educating and influencing the industry throughout their buying process.</p> </div> <div class="subnav-item-content-more"> <a href="/discovery-development/digital-marketing-services" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> </div> </div> </li> <li class="navbar-nav-item"> <a href="#" class="navbar-nav-item-link">Resources <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-graphics"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Header%20Resources.jpg" class="subnav-image"> </div> <div class="subnav-items"> <div class="subnav-item flex-2 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> Browse All Resources </h3> <p>Scientific & technical insights on the latest targets, platforms and processes impacting drug discovery & development.</p> </div> <div class="subnav-item-content-more"> <a href="/discovery-development/resources" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> All Discovery & Development Resources</a> </div> </div> <div class="subnav-item flex-4 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> Latest Resources </h3> <div class="resources"> <div class="resource"> <div class="resource-cover"> <a href="/discovery-development/resources/biomedgpt-adopting-a-generalist-approach-to-biomedical-ai" class="resource-cover-link"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Resources/Discovery%20and%20Development/BiomedGPT%20Adopting%20a%20Generalist%20Approach%20to%20Biomedical%20AI%20.png" class="resource-cover-image"> </a> </div> <div class="resource-content"> <h3 class="resource-heading"> <a href="/discovery-development/resources/biomedgpt-adopting-a-generalist-approach-to-biomedical-ai">BiomedGPT: Adopting a Generalist Approach to Biomedical AI </a> </h3> <div class="resource-abstract"> <span class="resource-date">11/11/24 - </span> BiomedGPT, a versatile AI tool used for biomedical research demonstrated impressive results across a wide range of healthcare tasks. </div> </div> </div> <div class="top-divider"></div> <div class="resource"> <div class="other-resources"><a href="/discovery-development/resources/the-application-of-rnai-therapeutics-for-cardiovascular-disease-treatment">07/11/24 - The Application of RNAi Therapeutics for Cardiovascular Disease Treatment</a></div> </div> <div class="top-divider"></div> <div class="resource"> <div class="other-resources"><a href="/discovery-development/resources/ai-ml-advancements-in-drug-formulation-the-potential-of-self-driving-labs">16/10/24 - AI/ML Advancements in Drug Formulation – The Potential of Self-Driving Labs </a></div> </div> </div> </div> </div> <div class="subnav-item flex-3"> <div class="subnav-item-content bottom-mp-fix"> <h3> Featured Resource </h3> <div class="resources flex flex-column g-5"> <a href="https://oxfordglobal.com/discovery-development/resources/sponsored/case-studies/ardigen/advancing-drug-discovery-through-innovative-technologies-strategic-collaboration"> <div class="sponsor-resource flex-column"> <div class="resource-cover img-fluid"> <div class="sponsor-resource-cover-link"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Resources/Discovery/Advancing%20Drug%20Discovery%20Mock%20Up.png" class="sponsor-resource-bubble-image"> </div> </div> <div class="resource-content p-15"> <h3 class="resource-heading"> Advancing Drug Discovery Through Innovative Technologies & Strategic Collaboration </h3> <div class="resource-abstract"> A Concise Report Featuring Insights From The Prominent Thought Leaders Of Discovery & Automate 2024 </div> </div> </div> </a> </div> </div> </div> </div> </div> </li> <li class="navbar-nav-item show-sm hide-md hide-lg hide-xl"> <a href="javascript:postMessage({type:'HS_DISPLAY_CALL_TO_ACTION',id:130207947529});" class="navbar-nav-item-link">Contact</a> </li> <li class="navbar-nav-item show-sm hide-md hide-lg hide-xl"> <a href="#" class="navbar-nav-item-link">Our Brands <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-items"> <h2> Explore our brands </h2> <div class="desc"> Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges. </div> <div class="subnav-item"> <div class="subnav-item-content"> <a href="/">Oxford Global</a> </div> </div> <div class="subnav-item"> <div class="subnav-item-content"> <a href="/precision-medicine">Precision Medicine</a> </div> </div> <div class="subnav-item"> <div class="subnav-item-content"> <a href="/discovery-development">Discovery & Development</a> </div> </div> <div class="subnav-item"> <div class="subnav-item-content"> <a href="/nextgen-biomed">NextGen Biomed</a> </div> </div> </div> </div> </li> </ul> </div> <div class="flex flex-align-center hide-sm show-md show-lg show-xl"> <a href="javascript:postMessage({type:'HS_DISPLAY_CALL_TO_ACTION',id:130207947529});" class="navbar-button">Contact</a> </div> </div> </header></div> <main id="main-content"> <div class="resource-single"> <div class="header bg-primary-light"> <div class="container-wrapper"> <div class="wide-container header-container"> <div class="header-content flex-1"> <div class="heading-smallcaps"> Molecular Drug Design | Industry Spotlights & Insight Articles </div> <h1 class="heading"> AlphaFold: Momentary or Revolutionary? </h1> <div class="byline"> Edited by Tom Cohen | 06 October 2022 </div> <div class="abstract"> AlphaFold, using AI/ML to predict the structures of proteins, has jumped off the pages of sci-fi and landed into the labs of researchers… but is it any good? </div> </div> <div class="header-graphic flex-1"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Resources/Discovery/AdobeStock_32008243-scaled.jpg" class="header-graphic-image"> </div> </div> </div> </div> <div class="container-wrapper"> <div class="wide-container"> <div class="content"> <div class="content-body text-gap">  <p>In the 21<sup>st</sup> Century we have almost come to expect technologies crossing the boundaries of science-fiction into science-fact. In the most recent years, artificial intelligence and machine learning has become one of these incumbent technologies. AI and ML methods have made quite a splash in the world of computational biology. The Alphabet owned company DeepMind has promised to solve biology’s ‘grand challenge’: using AI to solve protein folding conformations with their AlphaFold technology.</p>   <p>Govinda Bhisetti, Principal Investigator and Head of Computational Chemistry at Biogen (currently Vice President, Computational Chemistry, Cellarity) hosted the panel discussion, <strong>The Use of AlphaFold: Something Useful or Complete Hype?</strong> at Oxford Global’s <strong>Discovery Europe 2022</strong> conference. Bhisetti said that getting experimental accuracy of a protein’s structure through prediction methods would be a huge achievement. “Because then,” he explained, “you wouldn’t have to wait years to get a crystal structure – you could just get it from the AlphaFold database.”</p>   <p>Bhisetti also touched upon several subsequent developments that have used AI/ML methods to solve protein folding since AlphaFold2. “RoseTTAFold have claimed that they can achieve similar accuracy to AlphaFold,” said Bhisetti. Both AlphaFold2 and RoseTTAFold have been released as open source to allow for collaboration between developers, Bhisetti added “you can run these algorithms yourself to predict a protein’s structure. This enables everybody all over the world to look at these predicted structures.”</p>   <p>Despite the obviously huge advances — such as AlphaFold2 winning CASP14 — like any other method, it is not perfect. Bhisetti stated that the software’s prediction of structures is not 100% accurate, “it’s more like 70%, which is still very impressive.”</p>   <h2>Biases and Limitations of AlphaFold </h2>   <p>Joining Bhisetti on the panel was Matthias Frech, Director of Molecular Interactions & Biophysics at Merck Healthcare KGaA. Frech said that he was surprised in the beginning by the power of AlphaFold, “crystallographers in the department were very much afraid about losing their jobs due to these developments,” he said. “However, we know now that this is definitely not the case.”</p>   <ul><li><a href="https://oxfordglobal.com/discovery/resources/alphafold-and-drug-design-has-ai-solved-biologys-grand-challenge/" target="_blank" rel="noreferrer noopener">AlphaFold and Drug Design: Has AI Solved Biology’s ‘Grand Challenge?’</a></li></ul>   <p></p>   <p>Frech has looked into the use of AlphaFold for structural biology and said that he had detected some limitations of the software. “It’s fine to use it for the time-being within known domains and in getting new models,” he confirmed, but pointed out that there were other difficulties. For example, Frech mentioned there were challenges in using AlphaFold to predict full-length proteins, protein complexes, and proteins with increased flexibility.</p>   <p>Frech then raised an interesting open question. “We have so far analysed public domain structures – for example those in the PDB (protein data bank),” he explained. Frech added “if we look into the history of structural biology, we have been using engineered protein constructs which are prone to crystallisation. So, there is a bias in the models which we derive, does this in turn mean that there is a bias in the model building by AlphaFold?”</p>   <p>Frech suggested that perhaps the information derived from AlphaFold could be used to get a good model for refining difficult proteins. “We are looking into the capability of AlphaFold derived information to be used in protein engineering,” continued Frech, adding that it was a huge learning endeavour that he and his team had only just started conducting.</p>   <p>Another advantage that Frech mentioned was the fact that surrogate models can be used for the proteins which cannot be crystalised. “What we do in structural biology and biophysics is always bring a package of data together: structural, thermodynamic, pharmacokinetic data, or any other affinity data. We also need to look into how we can support the AlphaFold models with these sorts of data.”</p>   <h2>How Much is Just Hype?</h2>   <p>Simone Fulle, Head of Molecular Modelling & Design at Novo Nordisk, said that “whether AlphaFold is hype or not depends on your expectation and your use-case.” Fulle explained that Novo Nordisk has a portfolio of peptide and protein drugs in their pipeline, so they find the technology to be synchronous to their use-case. However, Fulle was careful to point out that AlphaFold has not been game-changing yet: “Is AlphaFold revolutionising drug design? Probably not. Is it a useful tool? Definitely yes.”</p>   <blockquote class="wp-block-quote is-style-large"><p>“Is AlphaFold revolutionising drug design? Probably not. Is it a useful tool? Definitely yes.”</p></blockquote>   <p>Fulle asked us to consider a broader perspective when thinking about AlphaFold. Her interest in the tool started when AlphaFold-Multimer had launched. AlphaFold-Multimer is an extension of AlphaFold2 that focusses on predicting the structures of protein-protein complexes. “Those weren’t trained on monomers but on dimers which then allowed for the prediction of complex structures,” Fulle explained. Additions and spin-offs of AlphaFold join the cohort of AI/ML tools by the day, the broader perspective is the backbone idea that AlphaFold was spawned from.</p>   <ul><li><a href="https://oxfordglobal.com/discovery/resources/alphafold-and-drug-design-has-ai-solved-biologys-grand-challenge/" target="_blank" rel="noreferrer noopener">Artificial Intelligence for Drug Design and Discovery</a></li></ul>   <p></p>   <h2>Finding the Limitations of AlphaFold</h2>   <p>Michael Wilson, Co-Founder and CEO of DrugBank, said that it had been interesting to see how AlphaFold has managed to produce inferences from existing databases such as the PDB. He went on to comment that the technology had made a significant impact on drug discovery news due to its fast and vast improvements, “but I think there are a lot of lessons that we need to learn from it.”</p>   <p>Wilson said that the use of AlphaFold had now reached the stage where researchers were now conducting experiments to push the limits, “to build up trust in this tool in certain areas.” Building up that trust, according to Wilson, requires a greater understanding of the kind of information that researchers need to provide their models in order to make their predictions.</p>   <ul><li><a href="https://oxfordglobal.com/discovery/resources/predicting-the-intricacies-of-compound-protein-interactions-uses-of-molecular-dynamics-in-drug-discovery/" target="_blank" rel="noreferrer noopener">Predicting the Intricacies of Compound-Protein Interactions: Uses of Molecular Dynamics in Drug Discovery</a></li></ul>   <p></p>   <p>“It has been interesting to see so many people picking this tool up, using it, and performing experiments with the tool to understand how it works,” added Wilson. Even though AlphaFold was developed as a tool on the knowledge that researchers already had, Wilson said that “once it had been launched, people didn’t fully understand the limitations of the tool.” Wilson suggested that this could be an opportunity – “something to learn for the next versions of tools like AlphaFold would be how can we make tools that help explain those limitations better.</p>   <h2>One Small Step for Machine Learning?</h2>   <p>Richard Lewis, Director of Computer Aided Drug Design at Novartis, was optimistic about AlphaFold, although he expressed caution about setting expectations and not getting ahead of oneself. “AlphaFold is great. But its like the first space missions: Sputnik or Yuri Gagarin’s first manned mission. We may have taken the first step, but that didn’t mean we were going to immediately fly to Mars.”</p>   <p>Lewis said that with hindsight, AlphaFold2 was always going to be successful compared to physics-based methods: “I say that because if you look at the PDB, the number of novel folds that were discovered in structures had been rising and then began to plateau. So, we had started to saturate the data.” That being said, Lewis described AlphaFold as being able to provide a “fascinating insight” into proteins that were once difficult to obtain structural information for. “Now we can just look up those structures in the database.”</p>   <p>However, Lewis still advised caution. He advocated that researchers better understand how AlphaFold works: via pattern recognition followed by a physics-based method - “and it gives you a structure purely of the amino acids. No co-factors, no metals, no waters,” Lewis said. “Just imagine looking at a novel cytochrome P450 and there’s no heme in there! It makes no sense. A zinc finger with no zinc? We still have to solve those problems to actually turn it into something that might really drive decision making,” Lewis concluded.</p>   <p><em>Join and network with over 200 industry leaders at </em><a href="https://oxfordglobal.com/discovery-us/" target="_blank" rel="noreferrer noopener"><em>Discovery US: In-Person</em></a><em>, where we will address the latest advancements in target identification, validation and HIT optimisation.</em></p>  <div class="content-body-footer"> </div> </div> <div class="content-sidebar"> <div class="related-articles"> <h3 class="center">Related Resources</h3> <div class="article"> <a href="/discovery-development/resources/biomedgpt-adopting-a-generalist-approach-to-biomedical-ai"> <div class="cover-graphic"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Resources/Discovery%20and%20Development/BiomedGPT%20Adopting%20a%20Generalist%20Approach%20to%20Biomedical%20AI%20.png" class="cover-graphic-image"> </div> </a><div class="content"><a href="/discovery-development/resources/biomedgpt-adopting-a-generalist-approach-to-biomedical-ai"> <h4> BiomedGPT: Adopting a Generalist Approach to Biomedical AI </h4> <div class="abstract"> BiomedGPT, a versatile AI tool used for biomedical research demonstrated impressive results across a wide range of healthcare tasks. </div> <div class="read-more"> <a href="/discovery-development/resources/biomedgpt-adopting-a-generalist-approach-to-biomedical-ai" class="read-more-link">Read More</a> </div></a> </div> </div> <div class="article"> <a href="/discovery-development/resources/goserelin-acetate-vitaldose-eva-implant"> <div class="cover-graphic"> <img src="https://oxfordglobal.com/hubfs/Website/Documents/White%20paper%20upload%20LS%206-11-24/Discovery%20%26%20Development%20Whitepaper.png" class="cover-graphic-image"> </div> </a><div class="content"><a href="/discovery-development/resources/goserelin-acetate-vitaldose-eva-implant"> <h4> Goserelin Acetate – VitalDose® EVA Implant </h4> <div class="abstract"> </div> <div class="read-more"> <a href="/discovery-development/resources/goserelin-acetate-vitaldose-eva-implant" class="read-more-link">Read More</a> </div></a> </div> </div> </div> </div> </div> </div> </div> </div> <div class="newsletter-cta"> <h2 class="heading">Subscribe to our newsletter</h2> <div class="message"> Sign up for our monthly Newsletter to keep up with all things Discovery & Development </div> <div class="button-wrapper"> <a href="#" class="button hs-cta-trigger-button hs-cta-trigger-button-177049184347">Newsletter Sign-Up</a> </div> </div> </main> <div data-global-resource-path="git/og-stage/templates/partials/footer.html"><footer class="website-footer flex flex-column g-20"> <div class="footer-columns"> <div class="footer-column"> <a href="https://oxfordglobal.com" class="site-logo-link"> <img src="https://oxfordglobal.com/wp-content/uploads/2023/03/Oxford-Global-Logo-Stacked-Websize.png" class="site-logo"> </a> </div> <div class="footer-column"> <h3>Brands</h3> <ul> <li> <a href="/precision-medicine/">Precision Medicine</a> </li> <li> <a href="/discovery-development/">Discovery & Development</a> </li> <li> <a href="/nextgen-biomed/">NextGen Biomed</a> </li> </ul> </div> <div class="footer-column"> <h3>Services</h3> <ul> <li> <a href="https://oxfordglobal.com/in-person-services/"> In-Person Services </a> </li> <li> <a href="https://oxfordglobal.com/digital-marketing-services/"> Digital Marketing Services </a> </li> </ul> <h3>Upcoming Events</h3> <ul> <li> <a href="https://oxfordglobal.com/calendar/"> Event Calendar </a> </li> </ul> </div> <div class="footer-column"> <h3>Company</h3> <ul> <li class="elementor-icon-list-item"> <a href="https://oxfordglobal.com/about-us/"> About </a> </li> <li class="elementor-icon-list-item"> <a href="https://oxfordglobal.com/vacancies/"> Vacancies </a> </li> <li class="elementor-icon-list-item"> <a href="https://oxfordglobal.com/csr-policy/"> CSR Policy </a> </li> <li class="elementor-icon-list-item"> <a href="javascript:postMessage({type:'HS_DISPLAY_CALL_TO_ACTION',id:130207947529});"> Contact </a> </li> </ul> </div> <div class="footer-column"> <p> <a href="tel:+441865248455">+44 1865 248 455</a><br> <a href="mailto:help@oxfordglobal.com">help@oxfordglobal.com</a> </p> <p> <strong>Our UK Address:</strong><br> Godstow Court<br> Minns Business Park<br> Botley<br> Oxford, OX2 0JB </p> <p> <strong>Our US Address:</strong><br> 100 Cambridge Street<br> 14th Floor<br> Boston<br> MA 02114 </p> </div> </div> <div class="footer-bottom grid g-20"> <div class="span8 span12-sm span12-md flex flex-column g-10"> <div class="copyright"> © Oxford Global Marketing Ltd. All rights reserved. </div> <ul class="legal-links flex flex-row g-30 flex-column-sm g-sm-10"> <li><a href="https://oxfordglobal.com/legal/">Terms & Conditions</a></li> <li><a href="https://oxfordglobal.com/legal/privacy-policy/">Privacy Policy</a></li> <li><a href="https://oxfordglobal.com/legal/website-terms/">Cookies</a></li> <li><a href="https://www.wishagency.co.uk/" target="_BLANK">Digital Agency Wish</a></li> </ul> </div> <div class="span4 span12-sm span12-md flex-align-end"> <ul class="social-links flex flex-row flex-justify-end flex-justify-center-sm flex-justify-center-md g-30"> <li><a href="https://www.facebook.com/OGConferences/" target="_BLANK"><i class="fa-brands fa-square-facebook"></i></a></li> <li><a href="https://www.linkedin.com/company/oxford-global/" target="_BLANK"><i class="fa-brands fa-linkedin"></i></a></li> <li><a href="https://twitter.com/OGConferences" target="_BLANK"><i class="fa-brands fa-square-x-twitter"></i></a></li> </ul> </div> </div> </footer></div> </div> <script src="/hs/hsstatic/jquery-libs/static-1.1/jquery/jquery-1.7.1.js"></script> <script>hsjQuery = window['jQuery'];</script>  <script defer src="/hs/hsstatic/content-cwv-embed/static-1.1293/embed.js"></script> <script src="https://oxfordglobal.com/hs-fs/hub/8696823/hub_generated/template_assets/182600797781/1731148644227/git/og-stage/js/inlineSVG.min.js"></script> <script src="https://oxfordglobal.com/hs-fs/hub/8696823/hub_generated/template_assets/135724366742/1725380923802/git/og-stage/js/main.min.js"></script> <script> function getVideoId(url) { var regExp = /^.*(youtu.be\/|v\/|u\/\w\/|embed\/|watch\?v=|\&v=)([^#\&\?]*).*/; var match = url.match(regExp); if (match && match[2].length == 11) { return match[2]; } else { return false; } } function getVideoEmbed(id) { return '<iframe src="https://www.youtube.com/embed/' + id + '" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" allowfullscreen style="aspect-ratio: 16 / 9; width: 100%;"></iframe>'; } jQuery("div.content-body .wp-block-embed__wrapper:contains('youtu')").each(function() { var yt_url = $(this).html().trim(); var yt_id = getVideoId(yt_url); var yt_embed = getVideoEmbed(yt_id); $(this).html(yt_embed); }); </script>  <script type="text/javascript"> var _hsq = _hsq || []; _hsq.push(["setContentType", "standard-page"]); _hsq.push(["setCanonicalUrl", "https:\/\/oxfordglobal.com\/discovery-development\/resources\/alphafold-momentary-or-revolutionary"]); _hsq.push(["setPageId", "hubdb-177028096592-7642658-170712574224"]); _hsq.push(["setContentMetadata", { "contentPageId": "hubdb-177028096592-7642658-170712574224", "legacyPageId": "hubdb-177028096592-7642658-170712574224", "contentFolderId": null, "contentGroupId": null, "abTestId": null, "languageVariantId": 177028096592, "languageCode": "en", }]); </script> <script type="text/javascript" id="hs-script-loader" async defer src="/hs/scriptloader/8696823.js"></script>  <script type="text/javascript"> var hsVars = { render_id: "6b850550-a106-44a9-b770-16cfe70f04ef", ticks: 1732336411877, page_id: 177028096592, dynamic_page_id: "hubdb-177028096592-7642658-170712574224", content_group_id: 0, portal_id: 8696823, app_hs_base_url: "https://app.hubspot.com", cp_hs_base_url: "https://cp.hubspot.com", language: "en", analytics_page_type: "standard-page", scp_content_type: "", analytics_page_id: "hubdb-177028096592-7642658-170712574224", category_id: 1, folder_id: 0, is_hubspot_user: false } </script> <script defer src="/hs/hsstatic/HubspotToolsMenu/static-1.354/js/index.js"></script> </body></html>

CINXE.COM

AlphaFold: Momentary or Revolutionary?